{"gene":"GAD2","run_date":"2026-06-09T23:54:44","timeline":{"discoveries":[{"year":1992,"finding":"GAD65 and GAD67 are differentially expressed in non-neural peripheral tissues: GAD65 is specifically expressed in oviduct mucosal epithelial cells, while GAD67 is expressed in testicular spermatocytes/spermatids, demonstrating that GAD is not limited to neurons and GABA may have non-neurotransmission functions.","method":"Western blotting, immunoreactivity, Northern blotting with isoform-specific cDNA and antibody probes","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (Western blot, immunohistochemistry, hybridization) in single lab study","pmids":["1729406"],"is_preprint":false},{"year":1993,"finding":"GAD65 expressed in engineered Rat-1 fibroblasts via retroviral vector produces enzymatic activity more responsive to added pyridoxal phosphate (PLP) than GAD67, and GAD65 immunostaining associates with surfaces of large vesicle-like structures; cells expressing either isoform synthesize and release GABA.","method":"Retroviral cDNA expression, GAD enzymatic activity assay, immunostaining, GABA measurement","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — in vitro enzymatic reconstitution with multiple orthogonal methods in single lab","pmids":["8336154"],"is_preprint":false},{"year":1993,"finding":"Human islets express only GAD65 (not GAD67), while rat islets predominantly express GAD65, and mouse islets express both isoforms but at severalfold lower levels; human and rat islet GAD65 exists in both membrane-bound and soluble forms.","method":"Western blotting, immunoprecipitation, immunohistochemistry using isoform-specific antibodies and monoclonal autoantibodies","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (Western blot, IP, IHC), replicated across species in single rigorous study","pmids":["8243826"],"is_preprint":false},{"year":1994,"finding":"The GAD2 gene encoding GAD65 consists of 16 exons spanning more than 79 kb; transcription begins at a GC-rich TATA-less region; the exon-intron organization is largely conserved with GAD1 (GAD67) except at exons 1-3, suggesting both genes derive from a common ancestral GAD.","method":"Genomic cloning and characterization, primer extension assays","journal":"Genomics","confidence":"High","confidence_rationale":"Tier 1 / Strong — direct genomic sequencing and structural characterization with primer extension, comprehensive gene structure analysis","pmids":["8088791"],"is_preprint":false},{"year":1997,"finding":"The GAD65 basal promoter maps between -740 and -60 upstream of the ATG; transcription initiates at -228 in brain and P19 cells (and -280 in brain, -360 in P19 cells); a silencer element between -1652 and -1420 represses transcription from a heterologous promoter; GAD65 and GAD67 promoters share little sequence identity consistent with independent regulation.","method":"Primer extension assays, transient transfection reporter assays, deletion analysis","journal":"Developmental neuroscience","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct functional promoter dissection with multiple deletion constructs, single lab","pmids":["9445084"],"is_preprint":false},{"year":2000,"finding":"Increased expression of GAD65 in transgenic mouse pancreatic beta-cells elevates GABA levels and impairs first-phase insulin secretion in response to glucose, affecting a step proximal to or at the K-ATP channel, establishing GAD65-derived GABA as a negative regulator of insulin secretion.","method":"Transgenic mouse overexpression (RIP7-hGAD65), in vivo glucose tolerance tests, pancreas perfusion experiments","journal":"American journal of physiology. Endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean transgenic loss/gain of function with defined physiological phenotype, pancreas perfusion functional assay, single lab","pmids":["10950838"],"is_preprint":false},{"year":2000,"finding":"GAD65 autoantibodies enhance presentation of the immunodominant GAD65 274-286 epitope to T cells via Fc receptor-mediated uptake; enhancement is inhibited by anti-FcR monoclonal antibodies, demonstrating that antibody-complexed GAD65 is taken up by antigen-presenting cells through FcR.","method":"T-cell hybridoma stimulation assay, Fc receptor blocking with monoclonal antibodies, antigen presentation assay","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional blocking experiment with defined molecular mechanism, single lab","pmids":["11016444"],"is_preprint":false},{"year":2004,"finding":"Phosphorylation of GAD65 by protein kinase C epsilon activates GAD65 enzymatic activity; this effect is reversible by protein phosphatases. In contrast, GAD67 is inhibited by PKA-mediated phosphorylation at threonine 91 (T91), confirmed by site-directed mutagenesis (T91A abolishes phosphorylation and inhibition; T91D/E mimics phosphorylation effect).","method":"In vitro kinase assay with purified recombinant proteins, [32P]ATP incorporation, anti-phosphoserine/threonine immunoblotting, MALDI-TOF phosphosite identification, site-directed mutagenesis","journal":"Biochemistry","confidence":"High","confidence_rationale":"Tier 1 / Strong — in vitro reconstitution with purified recombinant proteins, radioisotope incorporation, MS phosphosite mapping, and mutagenesis validation in one study","pmids":["15147202"],"is_preprint":false},{"year":2007,"finding":"In GAD65 knockout mice, synaptic vesicles lacking GAD65 show upregulated VGAT expression and more efficiently transport cytosolic GABA into vesicles; both full-length and N-terminally truncated GAD65 bind to GABAergic synaptic vesicles, indicating the N-terminus is not required for vesicle anchoring; GAD65 plays a major role in GABA synthesis for synaptic transmission under normal physiological conditions.","method":"GAD65 knockout mouse studies, synaptic vesicle reconstitution assay with [3H]glutamate, Western blotting for VGAT","journal":"Brain research","confidence":"High","confidence_rationale":"Tier 1 / Strong — genetic knockout combined with in vitro vesicle reconstitution assay and domain truncation analysis","pmids":["17482148"],"is_preprint":false},{"year":2008,"finding":"GAD65 undergoes a palmitoylation cycle: prior to palmitoylation, GAD65 anchors to both ER and Golgi membranes; palmitoylation at Cys30 and Cys45 clears GAD65 from ER-Golgi and targets it to the trans-Golgi network and then to post-Golgi vesicular pathway toward presynaptic clusters. FRAP analysis identifies a rapid non-palmitoylated pool exchanging between cytosol and ER/Golgi, and a slow palmitoylation-competent pool replenishing Golgi via a non-vesicular depalmitoylation-repalmitoylation cycle.","method":"FRAP (fluorescence recovery after photobleaching), live-cell imaging of GAD65-GFP, palmitoylation-deficient mutant analysis","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 1 / Strong — FRAP with functional mutants, direct live-cell trafficking analysis, multiple orthogonal approaches in one study","pmids":["18230651"],"is_preprint":false},{"year":2008,"finding":"Crystal structure analysis of GAD65 reveals that B-cell autoepitopes cluster in two regions (ctc1 and ctc2) at the COOH-terminal domain; the C-terminal domain of GAD65 is structurally more flexible than the equivalent region in GAD67, and T-cell epitopes co-localize with B-cell epitope clusters on solvent-exposed surfaces; this structural flexibility likely explains GAD65's greater autoantigenicity compared to GAD67.","method":"Crystal structure analysis, mutagenesis-based epitope mapping with 11 human monoclonal antibodies, cross-inhibition radioimmunoprecipitation with recombinant Fab","journal":"Diabetes","confidence":"High","confidence_rationale":"Tier 1 / Strong — structural analysis combined with comprehensive mutagenesis and functional antibody binding assays","pmids":["18184926"],"is_preprint":false},{"year":2009,"finding":"The GAD2 (gad2) promoter contains three functional estrogen response elements (EREs): an ERE at -711 is essential for transactivation in both MCF-7 and neural cells; an ERE at -546 enhances transcription specifically in neural cells; an ERE at -1958 is inactive in neural cells but represses transcription in MCF-7 cells. Estradiol activates gad2 transcription via either ERalpha or ERbeta through a CREB-independent mechanism; ChIP confirms ERalpha binding to a DNA fragment containing the -546 and -711 EREs in mouse GABAergic N42 cells.","method":"Dual luciferase reporter assays, site-directed mutagenesis of EREs, chromatin immunoprecipitation (ChIP)","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1 / Strong — functional promoter mutagenesis combined with ChIP validation in neural cells, multiple orthogonal methods","pmids":["19587286"],"is_preprint":false},{"year":2010,"finding":"BDNF/TrkB signaling controls GAD65 transcription in a cell-autonomous manner in cortical interneurons via a Ras-ERK-CREB-dependent pathway; conditional ablation of TrkB in cortical interneurons causes decreased synaptically enriched GAD65 protein and mRNA levels.","method":"Conditional TrkB knockout in cortical interneurons, pharmacological pathway dissection (Ras-ERK-CREB), Western blotting, qRT-PCR","journal":"Cerebral cortex","confidence":"High","confidence_rationale":"Tier 2 / Strong — cell-type-specific conditional knockout with pathway pharmacological dissection and molecular readouts","pmids":["20739478"],"is_preprint":false},{"year":2011,"finding":"Persistent inflammatory and neuropathic pain epigenetically suppresses Gad2 (GAD65) transcription in rat brainstem nucleus raphe magnus through HDAC-mediated histone hypoacetylation, reducing GAD65 protein and impairing GABA synaptic inhibition; Gad2 knockout mice show sensitized pain behavior and impaired GABA synaptic function; HDAC inhibitors restore GAD65 activity and GABA synaptic function only in wild-type, not Gad2 knockout mice.","method":"Gad2 knockout mice, HDAC inhibitor treatment, chromatin immunoprecipitation for histone acetylation, electrophysiological recording of GABA synaptic function, behavioral pain assays","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with pharmacological rescue, electrophysiology, and epigenetic ChIP, multiple orthogonal methods","pmids":["21983856"],"is_preprint":false},{"year":2012,"finding":"Mutant huntingtin (mhtt) impairs GAD65 palmitoylation and disrupts its subcellular localization: GAD65 shifts from Golgi membrane association to cytosolic diffusion in cells expressing mhtt; overexpression of HIP14 (the palmitoyl transferase responsible for GAD65 palmitoylation in vivo) rescues both GAD65 palmitoylation and vesicle-associated GAD65 trafficking, establishing HIP14 as the writer of GAD65 palmitoylation.","method":"Neuronal cell lines expressing normal or mutant huntingtin, acyl-biotin exchange palmitoylation assay, subcellular fractionation, HIP14 overexpression rescue","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — palmitoylation assay with rescue experiment, single lab, cell line model","pmids":["22103299"],"is_preprint":false},{"year":2014,"finding":"GAD65 undergoes cofactor (PLP)-dependent conformational changes: molecular dynamics simulations reveal coupling between the C-terminal domain, catalytic loop, and PLP-binding domain that drives structural rearrangement, dimer opening, and autoinactivation of GAD65 into an apo form; small-angle X-ray scattering and fluorescence spectroscopy confirm that apoGAD65 exists as a conformational ensemble; antibody-binding kinetics show mutually induced conformational changes, implicating GAD65 structural flexibility in its autoantigenicity.","method":"Molecular dynamics simulations, small-angle X-ray scattering (SAXS), fluorescence spectroscopy, limited proteolysis, antibody-binding kinetics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 / Strong — multiple orthogonal biophysical methods (SAXS, fluorescence, MD, proteolysis) converging on same mechanism","pmids":["24927554"],"is_preprint":false},{"year":2015,"finding":"Prenatal immune activation (poly I:C maternal injection) increases 5-methylcytosine (5mC) levels at the GAD2 promoter region in offspring prefrontal cortex, with elevated MeCP2 binding at the GAD2 promoter, resulting in reduced GAD65 mRNA expression.","method":"Bisulfite sequencing/methylation analysis, chromatin immunoprecipitation (MeCP2), qRT-PCR in mouse model","journal":"Epigenetics","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP and methylation analysis with functional mRNA readout, single lab","pmids":["26575259"],"is_preprint":false},{"year":2016,"finding":"Pancreatic islet beta cells release GAD65 (along with IA-2 and proinsulin) in exosomes; anchoring of GAD65 to exosome-mimetic liposomes strongly boosts antigen presentation and T-cell activation in the context of HLA-DR4; cytokine-induced ER stress enhances exosome secretion and promotes exosomal release of immunostimulatory chaperones (calreticulin, Gp96, ORP150).","method":"Exosome isolation from rat and human islets, electron microscopy, Western blotting, exosome-mimetic liposome reconstitution, T-cell activation assays","journal":"Diabetes","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — exosome isolation with reconstitution experiment and functional T-cell readout, single lab","pmids":["27872147"],"is_preprint":false},{"year":2017,"finding":"Orexin cell activation rapidly recruits GAD65-expressing lateral hypothalamic (GAD65LH) neurons; internally initiated GAD65LH cell bursts precede and accompany spontaneous running bouts; selective chemogenetic silencing of GAD65LH neurons depresses voluntary locomotion; GAD65LH cell overactivation leads to hyperlocomotion, establishing this orexin-activated GAD65LH submodule as a governor of physical activity.","method":"Optogenetic circuit analysis, chemogenetic (DREADD) silencing, deep-brain calcium recordings in behaving GAD65-GFP mice","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — optogenetics and chemogenetics combined with in vivo recordings, multiple orthogonal methods establishing circuit function","pmids":["28396414"],"is_preprint":false},{"year":2019,"finding":"HDAC2 knockdown in rat spinal cord via lentiviral shRNA alleviates mechanical and thermal hyperalgesia after chronic constriction injury and increases GAD65 and KCC2 expression in the spinal cord, identifying GAD65 as a downstream target of HDAC2 in pain modulation.","method":"Lentiviral HDAC2 shRNA knockdown, Western blotting for GAD65 and KCC2, behavioral pain assays","journal":"Frontiers in neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — lentiviral knockdown with defined molecular and behavioral readouts, single lab","pmids":["31024248"],"is_preprint":false},{"year":2020,"finding":"GAD65 is rapidly released from cultured human beta-cells proportional to cell death within 4-24 hours of acute insult, and is detectable in plasma within 24 hours after intraportal islet transplantation in proportion to the number of implanted beta-cells, establishing GAD65 as a real-time marker of beta-cell destruction.","method":"Time-resolved fluorescence immunoassay for GAD65, in vitro beta-cell toxin treatment, clinical intraportal transplantation study","journal":"The Journal of clinical endocrinology and metabolism","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — functional in vitro assay combined with clinical validation, single group","pmids":["25816051"],"is_preprint":false},{"year":2020,"finding":"GAD65-knockout rats (generated by TALEN) have undetectable brain GAD65 protein, significantly lower brain GABA content, exhibit spontaneous seizures and paroxysmal EEG discharge at postnatal weeks 3-4, and suffer >80% premature lethality by postnatal days 17-23, demonstrating that GAD65-derived GABA is essential for suppression of epilepsy and survival, with a more severe phenotype in rats than mice reflecting the higher GAD65/GAD67 ratio in rat (and human) brain.","method":"TALEN-based GAD2 knockout in rats, Western blotting, immunohistochemistry, GABA quantification, EEG recording, behavioral observation","journal":"FASEB journal","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic knockout with EEG, biochemical, and histological validation across multiple orthogonal methods","pmids":["33236473"],"is_preprint":false},{"year":2014,"finding":"GAD65/GAD67 double-knockout mice exhibit 100% incidence of cleft palate and omphalocele (compared to 65.8%/58.9% in GAD67-KO alone), with intermediate severity between GAD67-KO and VGAT-KO mice, demonstrating that GAD65-mediated GABAergic transmission contributes to both palate and abdominal wall formation during development.","method":"GAD65/GAD67 double knockout mice, anatomical analysis of palate elevation and omphalocele, comparison across genetic knockout lines","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic epistasis via comparison of single and double KO phenotypes, anatomical quantification, single lab","pmids":["25545713"],"is_preprint":false},{"year":2009,"finding":"Adenoviral delivery of GAD65 gene into trigeminal ganglion satellite glial cells leads to GAD65 expression and GABA synthesis predominantly in SGCs; the resulting analgesic effect in the orofacial formalin test is blocked by the selective GABAA receptor antagonist bicuculline but not by GABAB antagonist CGP46381, demonstrating that GAD65-derived GABA acts on neuronal GABAA receptors to reduce pain.","method":"Adenoviral gene delivery (AdGAD65), immunohistochemistry, pharmacological receptor blockade, behavioral orofacial formalin pain test","journal":"Molecular pain","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — pharmacological dissection of receptor specificity with gene delivery model, single lab","pmids":["19656360"],"is_preprint":false},{"year":2003,"finding":"The GAD2 promoter SNP -243 A>G increases GAD2 promoter activity approximately 6-fold in the murine insulinoma cell line betaTC3 and induces a 6-fold higher affinity for nuclear extracts, providing a functional mechanism by which this variant could alter GAD65 expression.","method":"Reporter gene (luciferase) assay in betaTC3 cells, nuclear extract binding/electrophoretic mobility shift assay","journal":"PLoS biology","confidence":"Medium","confidence_rationale":"Tier 1 / Moderate — direct functional promoter assay with nuclear binding, single lab, replicated (though association with obesity not confirmed in later studies)","pmids":["14691540"],"is_preprint":false},{"year":2012,"finding":"LHA GAD65 neurons are intrinsically depolarized and fire action potentials spontaneously (unlike cortical GABAergic interneurons); they fall into four electrophysiological subtypes (fast spiking, late spiking, low threshold spiking, regular spiking); approximately 40% are directly inhibited by physiological increases in extracellular glucose; they do not express MCH or orexin/hypocretin peptides.","method":"Whole-cell patch-clamp in acute brain slices of GAD65-GFP transgenic mice, 3D biocytin morphological reconstruction, glucose perfusion experiments, immunohistochemistry","journal":"The Journal of physiology","confidence":"High","confidence_rationale":"Tier 2 / Strong — electrophysiology combined with morphological and immunochemical characterization, multiple orthogonal methods","pmids":["23184514"],"is_preprint":false}],"current_model":"GAD2 encodes GAD65, a PLP-dependent enzyme that synthesizes GABA preferentially at presynaptic terminals; it is anchored to Golgi membranes via a hydrophobic modification and cycles dynamically to post-Golgi vesicular compartments through a HIP14-mediated palmitoylation/depalmitoylation cycle at Cys30/Cys45; its enzymatic activity is activated by PKC-epsilon-mediated phosphorylation and regulated by PLP binding status (existing mainly as an inactive apo form that undergoes cofactor-dependent conformational changes involving C-terminal domain flexibility and dimer opening); GAD65 is the principal isoform supplying GABA for synaptic vesicle loading and activity-dependent inhibitory transmission, as demonstrated by knockout phenotypes (seizures, reduced synaptic GABA, developmental defects), and its transcription is regulated by BDNF/TrkB-Ras-ERK-CREB signaling, estrogen receptor binding to promoter EREs, and HDAC-mediated epigenetic modification."},"narrative":{"mechanistic_narrative":"GAD2 encodes GAD65, a pyridoxal-5'-phosphate (PLP)-dependent decarboxylase that synthesizes GABA and serves as the principal isoform supplying GABA for synaptic vesicle loading and inhibitory neurotransmission [PMID:17482148, PMID:33236473]. The enzyme exists largely as an inactive apo form that undergoes cofactor-dependent conformational changes—coupling between the C-terminal domain, catalytic loop, and PLP-binding domain drives dimer opening and autoinactivation, and the structurally flexible C-terminal region underlies GAD65's marked autoantigenicity relative to GAD67 [PMID:18184926, PMID:24927554]. Enzymatic activity is acutely upregulated by PKC-epsilon-mediated phosphorylation, an effect reversible by protein phosphatases, in contrast to PKA-mediated inhibition of GAD67 [PMID:15147202]. GAD65 is targeted to membranes through a palmitoylation cycle at Cys30/Cys45 written by the palmitoyl transferase HIP14, which clears it from ER/Golgi to the trans-Golgi network and onward via a post-Golgi vesicular pathway toward presynaptic clusters; disruption of this cycle by mutant huntingtin shifts GAD65 to cytosolic diffusion [PMID:18230651, PMID:22103299]. Loss of GAD65 lowers brain GABA and causes spontaneous seizures, premature lethality, and developmental defects including cleft palate and omphalocele, and epigenetic suppression of Gad2 underlies inflammatory and neuropathic pain states [PMID:33236473, PMID:25545713, PMID:21983856]. GAD2 transcription is controlled by BDNF/TrkB-Ras-ERK-CREB signaling, estrogen receptor binding to promoter EREs, and HDAC- and MeCP2-mediated epigenetic regulation [PMID:20739478, PMID:19587286, PMID:21983856, PMID:26575259]. Beyond the nervous system, GAD65 is the predominant islet isoform, acts as a negative regulator of glucose-stimulated insulin secretion, and is a major autoantigen whose release in exosomes and via beta-cell death drives FcR-mediated antigen presentation and T-cell activation [PMID:8243826, PMID:10950838, PMID:27872147, PMID:11016444].","teleology":[{"year":1992,"claim":"Established that GAD65 is not neuron-restricted, raising the possibility of non-neurotransmission GABA functions in peripheral tissues.","evidence":"Isoform-specific Western, immunohistochemistry, and Northern blotting across peripheral tissues","pmids":["1729406"],"confidence":"Medium","gaps":["No functional role for peripheral GABA defined","Did not address regulation of isoform-specific expression"]},{"year":1993,"claim":"Showed that GAD65 activity is more PLP-responsive than GAD67 and that the enzyme associates with vesicle-like structures, hinting at distinct cofactor regulation and membrane targeting.","evidence":"Retroviral GAD65 expression in Rat-1 fibroblasts with enzymatic assays, immunostaining, and GABA measurement; islet expression analysis by Western/IP/IHC","pmids":["8336154","8243826"],"confidence":"High","gaps":["Molecular basis of membrane association not defined","PLP dependence not yet linked to a structural mechanism"]},{"year":1994,"claim":"Defined GAD2 gene structure and its conservation with GAD1, framing the two GAD genes as products of a common ancestor under independent regulation.","evidence":"Genomic cloning, structural characterization, and primer extension","pmids":["8088791"],"confidence":"High","gaps":["Regulatory elements not functionally tested","Cis-elements driving cell-type specificity not mapped"]},{"year":1997,"claim":"Mapped the GAD65 basal promoter and a distal silencer, establishing the transcriptional control architecture distinct from GAD67.","evidence":"Primer extension and deletion reporter assays in brain and P19 cells","pmids":["9445084"],"confidence":"Medium","gaps":["Trans-acting factors at the silencer not identified","Did not link promoter elements to physiological signaling"]},{"year":2000,"claim":"Demonstrated a non-neuronal physiological role: GAD65-derived GABA negatively regulates glucose-stimulated insulin secretion in beta-cells.","evidence":"RIP7-hGAD65 transgenic mouse overexpression, glucose tolerance tests, pancreas perfusion","pmids":["10950838"],"confidence":"Medium","gaps":["Molecular target at/near K-ATP channel not identified","Loss-of-function not tested in islets"]},{"year":2000,"claim":"Identified an FcR-dependent route by which autoantibody-complexed GAD65 enhances antigen presentation, linking the enzyme to autoimmune T-cell activation.","evidence":"T-cell hybridoma stimulation with anti-FcR blocking antibodies","pmids":["11016444"],"confidence":"Medium","gaps":["In vivo relevance to diabetes onset not established","APC type and FcR subtype not fully resolved"]},{"year":2004,"claim":"Resolved isoform-divergent post-translational control: PKC-epsilon phosphorylation activates GAD65 whereas PKA phosphorylation at T91 inhibits GAD67.","evidence":"In vitro kinase assays with purified proteins, [32P] incorporation, MALDI-TOF phosphosite mapping, site-directed mutagenesis","pmids":["15147202"],"confidence":"High","gaps":["GAD65 phosphosite not pinpointed as precisely as GAD67 T91","Physiological stimulus driving PKC-epsilon phosphorylation not identified"]},{"year":2007,"claim":"Genetically established GAD65 as the major source of GABA for synaptic transmission and showed its vesicle anchoring does not require the N-terminus.","evidence":"GAD65 knockout mice, synaptic vesicle reconstitution with [3H]glutamate, VGAT Western blotting, truncation analysis","pmids":["17482148"],"confidence":"High","gaps":["Vesicle anchoring determinant not mapped","Compensatory VGAT upregulation mechanism unresolved"]},{"year":2008,"claim":"Defined the palmitoylation cycle that traffics GAD65 from ER/Golgi to post-Golgi presynaptic vesicular compartments, and identified the C-terminal structural flexibility behind its autoantigenicity.","evidence":"FRAP and live-cell imaging with palmitoylation-deficient mutants; crystal structure with antibody epitope mapping","pmids":["18230651","18184926"],"confidence":"High","gaps":["Palmitoyl transferase not yet identified in 2008","Depalmitoylation enzyme unknown"]},{"year":2009,"claim":"Defined estrogen-responsive transcriptional control of GAD2 via multiple promoter EREs and demonstrated GABAA-receptor-mediated analgesia from glial GAD65 expression.","evidence":"Luciferase reporter assays with ERE mutagenesis and ChIP in neural cells; adenoviral GAD65 delivery to satellite glia with pharmacological receptor blockade","pmids":["19587286","19656360"],"confidence":"High","gaps":["Physiological estrogen regulation of endogenous GAD2 not shown","Mechanism of glial GABA release not defined"]},{"year":2010,"claim":"Identified BDNF/TrkB-Ras-ERK-CREB signaling as a cell-autonomous driver of GAD65 transcription in cortical interneurons.","evidence":"Conditional TrkB knockout, pharmacological pathway dissection, Western/qRT-PCR","pmids":["20739478"],"confidence":"High","gaps":["Direct CREB binding to GAD2 promoter not mapped here","Activity-dependence of the pathway not quantified"]},{"year":2011,"claim":"Linked HDAC-mediated epigenetic suppression of Gad2 to impaired GABAergic inhibition in chronic pain, with HDAC inhibitor rescue requiring intact GAD65.","evidence":"Gad2 knockout mice, HDAC inhibitor treatment, histone-acetylation ChIP, electrophysiology, pain behavior","pmids":["21983856"],"confidence":"High","gaps":["Specific HDAC isoform not identified in this study","Recruitment of HDAC to Gad2 not mechanistically defined"]},{"year":2012,"claim":"Identified HIP14 as the palmitoyl transferase writing GAD65 palmitoylation and showed mutant huntingtin disrupts GAD65 membrane targeting.","evidence":"Acyl-biotin exchange palmitoylation assay, subcellular fractionation, HIP14 overexpression rescue in neuronal cell lines","pmids":["22103299"],"confidence":"Medium","gaps":["Single cell-line model, no in vivo confirmation","Functional consequence for GABA transmission not measured"]},{"year":2014,"claim":"Defined the PLP-dependent conformational mechanism of GAD65 autoinactivation and its developmental requirement in palate and abdominal wall formation.","evidence":"MD simulations, SAXS, fluorescence spectroscopy, limited proteolysis, antibody kinetics; GAD65/GAD67 double-knockout anatomical analysis","pmids":["24927554","25545713"],"confidence":"High","gaps":["Conformational ensemble not captured at atomic resolution in apo state","Developmental GABA target tissues not defined"]},{"year":2017,"claim":"Showed beta-cells release GAD65 in exosomes that potently boost antigen presentation, and that orexin-activated lateral hypothalamic GAD65 neurons govern voluntary physical activity.","evidence":"Exosome isolation, liposome reconstitution, T-cell assays; optogenetics, chemogenetic silencing, and in vivo calcium recordings in GAD65-GFP mice","pmids":["27872147","28396414"],"confidence":"High","gaps":["Trigger linking ER stress to exosomal GAD65 in vivo unresolved","Downstream targets of GAD65LH neurons not fully mapped"]},{"year":2020,"claim":"Demonstrated that GAD65-knockout rats recapitulate a severe seizure/lethality phenotype proportional to high GAD65 ratio and that circulating GAD65 marks real-time beta-cell destruction.","evidence":"TALEN GAD2 knockout rats with EEG, biochemistry, histology; time-resolved immunoassay in cultured beta-cells and transplant patients","pmids":["33236473","25816051"],"confidence":"High","gaps":["Mechanism of species-dependent severity not molecularly defined","Clearance kinetics of plasma GAD65 not characterized"]},{"year":null,"claim":"How acute post-translational regulation (PKC phosphorylation, PLP cofactor cycling, HIP14 palmitoylation) is coordinated in vivo to match GABA supply to activity-dependent inhibitory demand remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No integrated in vivo model linking trafficking, cofactor state, and phosphorylation","Depalmitoylating enzyme for GAD65 unidentified","GAD65 phosphosite for PKC-epsilon not precisely mapped"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0016829","term_label":"lyase activity","supporting_discovery_ids":[1,7,15]}],"localization":[{"term_id":"GO:0005794","term_label":"Golgi apparatus","supporting_discovery_ids":[9,14]},{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[9]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[8,9]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[2,14]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[8,21]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[22,12]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[11,12,13]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6,17]}],"complexes":[],"partners":["HIP14","VGAT"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q05329","full_name":"Glutamate decarboxylase 2","aliases":["65 kDa glutamic acid decarboxylase","GAD-65","Glutamate decarboxylase 65 kDa isoform"],"length_aa":585,"mass_kda":65.4,"function":"Catalyzes the production of GABA","subcellular_location":"Cytoplasm, cytosol; Cytoplasmic vesicle; Presynaptic cell membrane; Golgi apparatus membrane","url":"https://www.uniprot.org/uniprotkb/Q05329/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GAD2","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GAD2","total_profiled":1310},"omim":[{"mim_id":"611145","title":"SOLUTE CARRIER FAMILY 30 (ZINC TRANSPORTER), MEMBER 8; SLC30A8","url":"https://www.omim.org/entry/611145"},{"mim_id":"605363","title":"GLUTAMATE DECARBOXYLASE 1; GAD1","url":"https://www.omim.org/entry/605363"},{"mim_id":"600029","title":"DISTAL-LESS HOMEOBOX 1; DLX1","url":"https://www.omim.org/entry/600029"},{"mim_id":"600028","title":"DISTAL-LESS HOMEOBOX 5; DLX5","url":"https://www.omim.org/entry/600028"},{"mim_id":"312750","title":"RETT SYNDROME; RTT","url":"https://www.omim.org/entry/312750"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":65.4}],"url":"https://www.proteinatlas.org/search/GAD2"},"hgnc":{"alias_symbol":["GAD65"],"prev_symbol":[]},"alphafold":{"accession":"Q05329","domains":[{"cath_id":"3.90.1150.170","chopping":"107-133_171-200_453-585","consensus_level":"medium","plddt":97.6682,"start":107,"end":585},{"cath_id":"3.40.640.10","chopping":"203-449","consensus_level":"high","plddt":97.8503,"start":203,"end":449}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q05329","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q05329-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q05329-F1-predicted_aligned_error_v6.png","plddt_mean":89.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GAD2","jax_strain_url":"https://www.jax.org/strain/search?query=GAD2"},"sequence":{"accession":"Q05329","fasta_url":"https://rest.uniprot.org/uniprotkb/Q05329.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q05329/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q05329"}},"corpus_meta":[{"pmid":"22296077","id":"PMC_22296077","title":"GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus.","date":"2012","source":"The New England journal of medicine","url":"https://pubmed.ncbi.nlm.nih.gov/22296077","citation_count":254,"is_preprint":false},{"pmid":"15115742","id":"PMC_15115742","title":"Preferential origin and layer destination of GAD65-GFP cortical interneurons.","date":"2004","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/15115742","citation_count":241,"is_preprint":false},{"pmid":"21983856","id":"PMC_21983856","title":"Epigenetic suppression of GAD65 expression mediates persistent pain.","date":"2011","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/21983856","citation_count":227,"is_preprint":false},{"pmid":"7561152","id":"PMC_7561152","title":"Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands.","date":"1995","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/7561152","citation_count":184,"is_preprint":false},{"pmid":"8243826","id":"PMC_8243826","title":"Differential expression of GAD65 and GAD67 in human, rat, and mouse pancreatic islets.","date":"1993","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/8243826","citation_count":177,"is_preprint":false},{"pmid":"32123047","id":"PMC_32123047","title":"Neurologic syndromes related to anti-GAD65: Clinical and serologic response to treatment.","date":"2020","source":"Neurology(R) neuroimmunology & neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/32123047","citation_count":170,"is_preprint":false},{"pmid":"27872147","id":"PMC_27872147","title":"Primary Human and Rat β-Cells Release the Intracellular Autoantigens GAD65, IA-2, and Proinsulin in Exosomes Together With Cytokine-Induced Enhancers of Immunity.","date":"2016","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/27872147","citation_count":168,"is_preprint":false},{"pmid":"10441235","id":"PMC_10441235","title":"Up-regulation of GAD65 and GAD67 in remaining hippocampal GABA neurons in a model of temporal lobe epilepsy.","date":"1999","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/10441235","citation_count":142,"is_preprint":false},{"pmid":"26575259","id":"PMC_26575259","title":"Maternal immune activation induces GAD1 and GAD2 promoter remodeling in the offspring prefrontal cortex.","date":"2015","source":"Epigenetics","url":"https://pubmed.ncbi.nlm.nih.gov/26575259","citation_count":109,"is_preprint":false},{"pmid":"14691540","id":"PMC_14691540","title":"GAD2 on chromosome 10p12 is a candidate gene for human obesity.","date":"2003","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/14691540","citation_count":98,"is_preprint":false},{"pmid":"1729406","id":"PMC_1729406","title":"Glutamate decarboxylases in nonneural cells of rat testis and oviduct: differential expression of GAD65 and GAD67.","date":"1992","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1729406","citation_count":92,"is_preprint":false},{"pmid":"20739478","id":"PMC_20739478","title":"CREB-Dependent Regulation of GAD65 Transcription by BDNF/TrkB in Cortical Interneurons.","date":"2010","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/20739478","citation_count":83,"is_preprint":false},{"pmid":"9075795","id":"PMC_9075795","title":"Combined analysis and single-step detection of GAD65 and IA2 autoantibodies in IDDM can replace the histochemical islet cell antibody test.","date":"1997","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/9075795","citation_count":77,"is_preprint":false},{"pmid":"9314633","id":"PMC_9314633","title":"Associations of GAD65- and IA-2- autoantibodies with genetic risk markers in new-onset IDDM patients and their siblings. The Belgian Diabetes Registry.","date":"1997","source":"Diabetes care","url":"https://pubmed.ncbi.nlm.nih.gov/9314633","citation_count":74,"is_preprint":false},{"pmid":"16249070","id":"PMC_16249070","title":"Comparative study of GAD65-specific CD4+ T cells in healthy and type 1 diabetic subjects.","date":"2005","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/16249070","citation_count":73,"is_preprint":false},{"pmid":"11295462","id":"PMC_11295462","title":"Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart.","date":"2001","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11295462","citation_count":72,"is_preprint":false},{"pmid":"8088791","id":"PMC_8088791","title":"The exon-intron organization of the genes (GAD1 and GAD2) encoding two human glutamate decarboxylases (GAD67 and GAD65) suggests that they derive from a common ancestral GAD.","date":"1994","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/8088791","citation_count":68,"is_preprint":false},{"pmid":"28396414","id":"PMC_28396414","title":"Orexin-driven GAD65 network of the lateral hypothalamus sets physical activity in mice.","date":"2017","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/28396414","citation_count":66,"is_preprint":false},{"pmid":"11016444","id":"PMC_11016444","title":"GAD65-specific autoantibodies enhance the presentation of an immunodominant T-cell epitope from GAD65.","date":"2000","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11016444","citation_count":66,"is_preprint":false},{"pmid":"10950838","id":"PMC_10950838","title":"Increased expression of GAD65 and GABA in pancreatic beta-cells impairs first-phase insulin secretion.","date":"2000","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/10950838","citation_count":63,"is_preprint":false},{"pmid":"10868836","id":"PMC_10868836","title":"Antibodies to IA-2 and GAD65 in type 1 and type 2 diabetes: isotype restriction and polyclonality.","date":"2000","source":"Diabetes care","url":"https://pubmed.ncbi.nlm.nih.gov/10868836","citation_count":63,"is_preprint":false},{"pmid":"9480718","id":"PMC_9480718","title":"Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.","date":"1998","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/9480718","citation_count":59,"is_preprint":false},{"pmid":"11473034","id":"PMC_11473034","title":"Characterization of preparations of GAD65, proinsulin, and the islet tyrosine phosphatase IA-2 for use in detection of autoreactive T-cells in type 1 diabetes: report of phase II of the Second International Immunology of Diabetes Society Workshop for Standardization of T-cell assays in type 1 diabetes.","date":"2001","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11473034","citation_count":59,"is_preprint":false},{"pmid":"23114513","id":"PMC_23114513","title":"GAD65, GAD67, and GABAT immunostaining in human brain and apparent GAD65 loss in Alzheimer's disease.","date":"2013","source":"Journal of Alzheimer's disease : JAD","url":"https://pubmed.ncbi.nlm.nih.gov/23114513","citation_count":55,"is_preprint":false},{"pmid":"23184514","id":"PMC_23184514","title":"Lateral hypothalamic GAD65 neurons are spontaneously firing and distinct from orexin- and melanin-concentrating hormone neurons.","date":"2012","source":"The Journal of physiology","url":"https://pubmed.ncbi.nlm.nih.gov/23184514","citation_count":55,"is_preprint":false},{"pmid":"17482148","id":"PMC_17482148","title":"Role of glutamate decarboxylase (GAD) isoform, GAD65, in GABA synthesis and transport into synaptic vesicles-Evidence from GAD65-knockout mice studies.","date":"2007","source":"Brain research","url":"https://pubmed.ncbi.nlm.nih.gov/17482148","citation_count":52,"is_preprint":false},{"pmid":"18230651","id":"PMC_18230651","title":"A palmitoylation cycle dynamically regulates partitioning of the GABA-synthesizing enzyme GAD65 between ER-Golgi and post-Golgi membranes.","date":"2008","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/18230651","citation_count":52,"is_preprint":false},{"pmid":"25470336","id":"PMC_25470336","title":"The GAD65 knock out mouse - a model for GABAergic processes in fear- and stress-induced psychopathology.","date":"2015","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/25470336","citation_count":51,"is_preprint":false},{"pmid":"25681349","id":"PMC_25681349","title":"High diversity in the TCR repertoire of GAD65 autoantigen-specific human CD4+ T cells.","date":"2015","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/25681349","citation_count":51,"is_preprint":false},{"pmid":"9099922","id":"PMC_9099922","title":"Antibody cross-reactivity induced by the homologous regions in glutamic acid decarboxylase (GAD65) and 2C protein of coxsackievirus B4. Childhood Diabetes in Finland Study Group.","date":"1996","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/9099922","citation_count":50,"is_preprint":false},{"pmid":"19587286","id":"PMC_19587286","title":"The gad2 promoter is a transcriptional target of estrogen receptor (ER)alpha and ER beta: a unifying hypothesis to explain diverse effects of estradiol.","date":"2009","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19587286","citation_count":49,"is_preprint":false},{"pmid":"15147202","id":"PMC_15147202","title":"Protein phosphorylation of human brain glutamic acid decarboxylase (GAD)65 and GAD67 and its physiological implications.","date":"2004","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15147202","citation_count":49,"is_preprint":false},{"pmid":"22869930","id":"PMC_22869930","title":"GAD65 autoantibodies and its role as biomarker of Type 1 diabetes and Latent Autoimmune Diabetes in Adults (LADA).","date":"2011","source":"Drugs of the future","url":"https://pubmed.ncbi.nlm.nih.gov/22869930","citation_count":49,"is_preprint":false},{"pmid":"9777630","id":"PMC_9777630","title":"Are GAD65 and GAD67 associated with specific pools of GABA in brain?","date":"1998","source":"Perspectives on developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9777630","citation_count":48,"is_preprint":false},{"pmid":"27855137","id":"PMC_27855137","title":"Garcinol Upregulates GABAA and GAD65 Expression, Modulates BDNF-TrkB Pathway to Reduce Seizures in Pentylenetetrazole (PTZ)-Induced Epilepsy.","date":"2016","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/27855137","citation_count":47,"is_preprint":false},{"pmid":"7926302","id":"PMC_7926302","title":"Glutamic acid decarboxylase (GAD65) autoantibodies in prediction of beta-cell function and remission in recent-onset IDDM after cyclosporin treatment. The Canadian-European Randomized Control Trial Group.","date":"1994","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/7926302","citation_count":46,"is_preprint":false},{"pmid":"19656360","id":"PMC_19656360","title":"Adenovector GAD65 gene delivery into the rat trigeminal ganglion produces orofacial analgesia.","date":"2009","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/19656360","citation_count":45,"is_preprint":false},{"pmid":"9427477","id":"PMC_9427477","title":"Expression of two forms of glutamic acid decarboxylase (GAD67 and GAD65) during postnatal development of the cat visual cortex.","date":"1997","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/9427477","citation_count":45,"is_preprint":false},{"pmid":"18633686","id":"PMC_18633686","title":"Immunohistochemical localization of GABA, GAD65, and the receptor subunits GABAAalpha1 and GABAB1 in the zebrafish cerebellum.","date":"2008","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/18633686","citation_count":44,"is_preprint":false},{"pmid":"22323074","id":"PMC_22323074","title":"Presence of GAD65 autoantibodies in the serum of children with autism or ADHD.","date":"2012","source":"European child & adolescent psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22323074","citation_count":44,"is_preprint":false},{"pmid":"10330300","id":"PMC_10330300","title":"GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.","date":"1999","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/10330300","citation_count":44,"is_preprint":false},{"pmid":"9831046","id":"PMC_9831046","title":"Expression of two forms of glutamic acid decarboxylase (GAD67 and GAD65) during postnatal development of rat somatosensory barrel cortex.","date":"1998","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/9831046","citation_count":40,"is_preprint":false},{"pmid":"18706702","id":"PMC_18706702","title":"Autoantibodies to GAD65 and IA-2 in canine diabetes mellitus.","date":"2008","source":"Veterinary immunology and immunopathology","url":"https://pubmed.ncbi.nlm.nih.gov/18706702","citation_count":39,"is_preprint":false},{"pmid":"12401715","id":"PMC_12401715","title":"Induction of autoimmune diabetes through insulin (but not GAD65) DNA vaccination in nonobese diabetic and in RIP-B7.1 mice.","date":"2002","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12401715","citation_count":39,"is_preprint":false},{"pmid":"9707599","id":"PMC_9707599","title":"Widespread expression of an autoantigen-GAD65 transgene does not tolerize non-obese diabetic mice and can exacerbate disease.","date":"1998","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/9707599","citation_count":38,"is_preprint":false},{"pmid":"15854751","id":"PMC_15854751","title":"Visualization of stress-responsive inhibitory circuits in the GAD65-eGFP transgenic mice.","date":"2005","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/15854751","citation_count":38,"is_preprint":false},{"pmid":"16122350","id":"PMC_16122350","title":"Lack of support for the association between GAD2 polymorphisms and severe human obesity.","date":"2005","source":"PLoS biology","url":"https://pubmed.ncbi.nlm.nih.gov/16122350","citation_count":37,"is_preprint":false},{"pmid":"11473032","id":"PMC_11473032","title":"Expression of GAD65 and islet cell antibody (ICA512) autoantibodies among cytoplasmic ICA+ relatives is associated with eligibility for the Diabetes Prevention Trial-Type 1.","date":"2001","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/11473032","citation_count":37,"is_preprint":false},{"pmid":"7962709","id":"PMC_7962709","title":"Transient increase in expression of GAD65 and GAD67 mRNAs during postnatal development of rat spinal cord.","date":"1994","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/7962709","citation_count":37,"is_preprint":false},{"pmid":"18184926","id":"PMC_18184926","title":"COOH-terminal clustering of autoantibody and T-cell determinants on the structure of GAD65 provide insights into the molecular basis of autoreactivity.","date":"2008","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/18184926","citation_count":37,"is_preprint":false},{"pmid":"24927554","id":"PMC_24927554","title":"Cofactor-dependent conformational heterogeneity of GAD65 and its role in autoimmunity and neurotransmitter homeostasis.","date":"2014","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/24927554","citation_count":36,"is_preprint":false},{"pmid":"32332079","id":"PMC_32332079","title":"GAD2 Expression Defines a Class of Excitatory Lateral Habenula Neurons in Mice that Project to the Raphe and Pontine Tegmentum.","date":"2020","source":"eNeuro","url":"https://pubmed.ncbi.nlm.nih.gov/32332079","citation_count":35,"is_preprint":false},{"pmid":"23421475","id":"PMC_23421475","title":"Genetic manipulation of the γ-aminobutyric acid (GABA) shunt in rice: overexpression of truncated glutamate decarboxylase (GAD2) and knockdown of γ-aminobutyric acid transaminase (GABA-T) lead to sustained and high levels of GABA accumulation in rice kernels.","date":"2013","source":"Plant biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/23421475","citation_count":35,"is_preprint":false},{"pmid":"19229853","id":"PMC_19229853","title":"Polymorphisms in the GAD2 gene-region are associated with susceptibility for unipolar depression and with a risk factor for anxiety disorders.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19229853","citation_count":34,"is_preprint":false},{"pmid":"25147515","id":"PMC_25147515","title":"GAD65 haplodeficiency conveys resilience in animal models of stress-induced psychopathology.","date":"2014","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25147515","citation_count":34,"is_preprint":false},{"pmid":"19690518","id":"PMC_19690518","title":"Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes.","date":"2009","source":"Molecular therapy : the journal of the American Society of Gene Therapy","url":"https://pubmed.ncbi.nlm.nih.gov/19690518","citation_count":34,"is_preprint":false},{"pmid":"9669322","id":"PMC_9669322","title":"Elevation of brain GABA levels with vigabatrin (gamma-vinylGABA) differentially affects GAD65 and GAD67 expression in various regions of rat brain.","date":"1998","source":"Journal of neuroscience research","url":"https://pubmed.ncbi.nlm.nih.gov/9669322","citation_count":33,"is_preprint":false},{"pmid":"10439311","id":"PMC_10439311","title":"CD4+ and CD8+ T-cell clones from congenital rubella syndrome patients with IDDM recognize overlapping GAD65 protein epitopes. Implications for HLA class I and II allelic linkage to disease susceptibility.","date":"1999","source":"Human immunology","url":"https://pubmed.ncbi.nlm.nih.gov/10439311","citation_count":31,"is_preprint":false},{"pmid":"22414751","id":"PMC_22414751","title":"Transcriptional control of Gad2.","date":"2012","source":"Transcription","url":"https://pubmed.ncbi.nlm.nih.gov/22414751","citation_count":30,"is_preprint":false},{"pmid":"15882945","id":"PMC_15882945","title":"Expression of GAD65 and GAD67 immunoreactivity in MPTP-treated monkeys with or without L-DOPA administration.","date":"2005","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/15882945","citation_count":30,"is_preprint":false},{"pmid":"15671113","id":"PMC_15671113","title":"Is glutamate decarboxylase 2 (GAD2) a genetic link between low birth weight and subsequent development of obesity in children?","date":"2005","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15671113","citation_count":30,"is_preprint":false},{"pmid":"25545713","id":"PMC_25545713","title":"GAD65/GAD67 double knockout mice exhibit intermediate severity in both cleft palate and omphalocele compared with GAD67 knockout and VGAT knockout mice.","date":"2014","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25545713","citation_count":30,"is_preprint":false},{"pmid":"31024248","id":"PMC_31024248","title":"Normalizing HDAC2 Levels in the Spinal Cord Alleviates Thermal and Mechanical Hyperalgesia After Peripheral Nerve Injury and Promotes GAD65 and KCC2 Expression.","date":"2019","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/31024248","citation_count":28,"is_preprint":false},{"pmid":"7772705","id":"PMC_7772705","title":"Autoantibodies against GAD65 rather than GAD67 precede the onset of type 1 diabetes.","date":"1994","source":"Autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/7772705","citation_count":27,"is_preprint":false},{"pmid":"26797873","id":"PMC_26797873","title":"Vaccination with a co-expression DNA plasmid containing GAD65 fragment gene and IL-10 gene induces regulatory CD4(+) T cells that prevent experimental autoimmune diabetes.","date":"2016","source":"Diabetes/metabolism research and reviews","url":"https://pubmed.ncbi.nlm.nih.gov/26797873","citation_count":26,"is_preprint":false},{"pmid":"29315430","id":"PMC_29315430","title":"Swimming Training Attenuates Allodynia and Hyperalgesia Induced by Peripheral Nerve Injury in an Adult Male Rat Neuropathic Model: Effects on Irisin and GAD65.","date":"2018","source":"Pain medicine (Malden, Mass.)","url":"https://pubmed.ncbi.nlm.nih.gov/29315430","citation_count":26,"is_preprint":false},{"pmid":"15220192","id":"PMC_15220192","title":"HLA-DQ-regulated T-cell responses to islet cell autoantigens insulin and GAD65.","date":"2004","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/15220192","citation_count":25,"is_preprint":false},{"pmid":"15963796","id":"PMC_15963796","title":"Sensitive non-isotopic assays for autoantibodies to IA-2 and to a combination of both IA-2 and GAD65.","date":"2005","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15963796","citation_count":25,"is_preprint":false},{"pmid":"20086252","id":"PMC_20086252","title":"Comparison of radioimmunoprecipitation with luciferase immunoprecipitation for autoantibodies to GAD65 and IA-2beta.","date":"2010","source":"Diabetes care","url":"https://pubmed.ncbi.nlm.nih.gov/20086252","citation_count":24,"is_preprint":false},{"pmid":"26848839","id":"PMC_26848839","title":"GAD2 Alternative Transcripts in the Human Prefrontal Cortex, and in Schizophrenia and Affective Disorders.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26848839","citation_count":23,"is_preprint":false},{"pmid":"29377906","id":"PMC_29377906","title":"Enhanced susceptibility to stress and seizures in GAD65 deficient mice.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29377906","citation_count":23,"is_preprint":false},{"pmid":"17279576","id":"PMC_17279576","title":"Visualization of two distinct classes of neurons by gad2 and zic1 promoter/enhancer elements in the dorsal hindbrain of developing zebrafish reveals neuronal connectivity related to the auditory and lateral line systems.","date":"2007","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/17279576","citation_count":23,"is_preprint":false},{"pmid":"8816971","id":"PMC_8816971","title":"Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity.","date":"1996","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/8816971","citation_count":23,"is_preprint":false},{"pmid":"22103299","id":"PMC_22103299","title":"Palmitoylation and trafficking of GAD65 are impaired in a cellular model of Huntington's disease.","date":"2012","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/22103299","citation_count":22,"is_preprint":false},{"pmid":"9445084","id":"PMC_9445084","title":"Multiple elements regulate GAD65 transcription.","date":"1997","source":"Developmental neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/9445084","citation_count":21,"is_preprint":false},{"pmid":"17034009","id":"PMC_17034009","title":"Mutation screen of the GAD2 gene and association study of alcoholism in three populations.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17034009","citation_count":20,"is_preprint":false},{"pmid":"20002022","id":"PMC_20002022","title":"Mice lacking Gad2 show altered behavioral effects of ethanol, flurazepam and gabaxadol.","date":"2010","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/20002022","citation_count":20,"is_preprint":false},{"pmid":"27242441","id":"PMC_27242441","title":"Anti-GAD65 Containing Cerebrospinal Fluid Does not Alter GABAergic Transmission.","date":"2016","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/27242441","citation_count":20,"is_preprint":false},{"pmid":"25816051","id":"PMC_25816051","title":"Plasma GAD65, a Marker for Early β-Cell Loss After Intraportal Islet Cell Transplantation in Diabetic Patients.","date":"2015","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25816051","citation_count":20,"is_preprint":false},{"pmid":"23437266","id":"PMC_23437266","title":"Immunoreactivity for GABA, GAD65, GAD67 and Bestrophin-1 in the meninges and the choroid plexus: implications for non-neuronal sources for GABA in the developing mouse brain.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23437266","citation_count":20,"is_preprint":false},{"pmid":"8336154","id":"PMC_8336154","title":"Rat-1 fibroblasts engineered with GAD65 and GAD67 cDNAs in retroviral vectors produce and release GABA.","date":"1993","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8336154","citation_count":20,"is_preprint":false},{"pmid":"18514483","id":"PMC_18514483","title":"GAD65 as a prototypic autoantigen.","date":"2008","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/18514483","citation_count":19,"is_preprint":false},{"pmid":"32728596","id":"PMC_32728596","title":"AAV-Mediated Combination Gene Therapy for Neuropathic Pain: GAD65, GDNF, and IL-10.","date":"2020","source":"Molecular therapy. Methods & clinical development","url":"https://pubmed.ncbi.nlm.nih.gov/32728596","citation_count":19,"is_preprint":false},{"pmid":"37607753","id":"PMC_37607753","title":"Cenobamate and Clobazam Combination as Personalized Medicine in Autoimmune-Associated Epilepsy With Anti-Gad65 Antibodies.","date":"2023","source":"Neurology(R) neuroimmunology & neuroinflammation","url":"https://pubmed.ncbi.nlm.nih.gov/37607753","citation_count":19,"is_preprint":false},{"pmid":"34803625","id":"PMC_34803625","title":"Heterogeneous GAD65 Expression in Subtypes of GABAergic Neurons Across Layers of the Cerebral Cortex and Hippocampus.","date":"2021","source":"Frontiers in behavioral neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/34803625","citation_count":18,"is_preprint":false},{"pmid":"16731858","id":"PMC_16731858","title":"Significant linkage of BMI to chromosome 10p in the U.K. population and evaluation of GAD2 as a positional candidate.","date":"2006","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/16731858","citation_count":18,"is_preprint":false},{"pmid":"31264387","id":"PMC_31264387","title":"Exercise training increases GAD65 expression, restores the depressed GABAA receptor function within the PVN and reduces sympathetic modulation in hypertension.","date":"2019","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/31264387","citation_count":18,"is_preprint":false},{"pmid":"9179463","id":"PMC_9179463","title":"Combined measurements of GAD65 and ICA512 antibodies in acute onset and slowly progressive IDDM.","date":"1997","source":"Diabetes research and clinical practice","url":"https://pubmed.ncbi.nlm.nih.gov/9179463","citation_count":18,"is_preprint":false},{"pmid":"33236473","id":"PMC_33236473","title":"Rats deficient in the GAD65 isoform exhibit epilepsy and premature lethality.","date":"2020","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/33236473","citation_count":17,"is_preprint":false},{"pmid":"19686769","id":"PMC_19686769","title":"GAD2 gene sequence variations are associated with eating behaviors and weight gain in women from the Quebec family study.","date":"2009","source":"Physiology & behavior","url":"https://pubmed.ncbi.nlm.nih.gov/19686769","citation_count":17,"is_preprint":false},{"pmid":"18637036","id":"PMC_18637036","title":"GAD65 IgG autoantibodies in stiff person syndrome: clonality, avidity and persistence.","date":"2008","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/18637036","citation_count":17,"is_preprint":false},{"pmid":"12196483","id":"PMC_12196483","title":"A comprehensive, statistically powered analysis of GAD2 in type 1 diabetes.","date":"2002","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/12196483","citation_count":16,"is_preprint":false},{"pmid":"12604315","id":"PMC_12604315","title":"T-cell function in anti-GAD65(+)diabetes with residual beta-cell function.","date":"2003","source":"Journal of autoimmunity","url":"https://pubmed.ncbi.nlm.nih.gov/12604315","citation_count":16,"is_preprint":false},{"pmid":"29518118","id":"PMC_29518118","title":"An analytical comparison of three immunoassay platforms for subpicomolar detection of protein biomarker GAD65.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29518118","citation_count":16,"is_preprint":false},{"pmid":"29724796","id":"PMC_29724796","title":"GAD65 Promoter Polymorphism rs2236418 Modulates Harm Avoidance in Women via Inhibition/Excitation Balance in the Rostral ACC.","date":"2018","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/29724796","citation_count":16,"is_preprint":false},{"pmid":"22291989","id":"PMC_22291989","title":"Combinational spinal GAD65 gene delivery and systemic GABA-mimetic treatment for modulation of spasticity.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22291989","citation_count":15,"is_preprint":false},{"pmid":"35196314","id":"PMC_35196314","title":"Similarities between bacterial GAD and human GAD65: Implications in gut mediated autoimmune type 1 diabetes.","date":"2022","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/35196314","citation_count":15,"is_preprint":false},{"pmid":"9368643","id":"PMC_9368643","title":"Highly-sensitive and specific enzyme-linked immunosorbent assays for GAD65 autoantibodies using a thioredoxin-GAD65 fusion antigen.","date":"1997","source":"Journal of immunological methods","url":"https://pubmed.ncbi.nlm.nih.gov/9368643","citation_count":15,"is_preprint":false},{"pmid":"30203041","id":"PMC_30203041","title":"Combined Analysis of GAD65, miR-375, and Unmethylated Insulin DNA Following Islet Transplantation in Patients With T1D.","date":"2019","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30203041","citation_count":14,"is_preprint":false},{"pmid":"33586515","id":"PMC_33586515","title":"Spinal GABAergic neurons are under feed-forward inhibitory control driven by Aδ and C fibers in Gad2 td-Tomato mice.","date":"2021","source":"Molecular pain","url":"https://pubmed.ncbi.nlm.nih.gov/33586515","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54442,"output_tokens":6574,"usd":0.130968,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":15596,"output_tokens":4868,"usd":0.09984,"stage2_stop_reason":"end_turn"},"total_usd":0.230808,"stage1_batch_id":"msgbatch_01AsR7g8dGTEiEw9U83bJeWn","stage2_batch_id":"msgbatch_01YV5ZyxtFNUZEjxRcpd9jzb","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"GAD65 and GAD67 are differentially expressed in non-neural peripheral tissues: GAD65 is specifically expressed in oviduct mucosal epithelial cells, while GAD67 is expressed in testicular spermatocytes/spermatids, demonstrating that GAD is not limited to neurons and GABA may have non-neurotransmission functions.\",\n      \"method\": \"Western blotting, immunoreactivity, Northern blotting with isoform-specific cDNA and antibody probes\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (Western blot, immunohistochemistry, hybridization) in single lab study\",\n      \"pmids\": [\"1729406\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"GAD65 expressed in engineered Rat-1 fibroblasts via retroviral vector produces enzymatic activity more responsive to added pyridoxal phosphate (PLP) than GAD67, and GAD65 immunostaining associates with surfaces of large vesicle-like structures; cells expressing either isoform synthesize and release GABA.\",\n      \"method\": \"Retroviral cDNA expression, GAD enzymatic activity assay, immunostaining, GABA measurement\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — in vitro enzymatic reconstitution with multiple orthogonal methods in single lab\",\n      \"pmids\": [\"8336154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1993,\n      \"finding\": \"Human islets express only GAD65 (not GAD67), while rat islets predominantly express GAD65, and mouse islets express both isoforms but at severalfold lower levels; human and rat islet GAD65 exists in both membrane-bound and soluble forms.\",\n      \"method\": \"Western blotting, immunoprecipitation, immunohistochemistry using isoform-specific antibodies and monoclonal autoantibodies\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (Western blot, IP, IHC), replicated across species in single rigorous study\",\n      \"pmids\": [\"8243826\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1994,\n      \"finding\": \"The GAD2 gene encoding GAD65 consists of 16 exons spanning more than 79 kb; transcription begins at a GC-rich TATA-less region; the exon-intron organization is largely conserved with GAD1 (GAD67) except at exons 1-3, suggesting both genes derive from a common ancestral GAD.\",\n      \"method\": \"Genomic cloning and characterization, primer extension assays\",\n      \"journal\": \"Genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — direct genomic sequencing and structural characterization with primer extension, comprehensive gene structure analysis\",\n      \"pmids\": [\"8088791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The GAD65 basal promoter maps between -740 and -60 upstream of the ATG; transcription initiates at -228 in brain and P19 cells (and -280 in brain, -360 in P19 cells); a silencer element between -1652 and -1420 represses transcription from a heterologous promoter; GAD65 and GAD67 promoters share little sequence identity consistent with independent regulation.\",\n      \"method\": \"Primer extension assays, transient transfection reporter assays, deletion analysis\",\n      \"journal\": \"Developmental neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct functional promoter dissection with multiple deletion constructs, single lab\",\n      \"pmids\": [\"9445084\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Increased expression of GAD65 in transgenic mouse pancreatic beta-cells elevates GABA levels and impairs first-phase insulin secretion in response to glucose, affecting a step proximal to or at the K-ATP channel, establishing GAD65-derived GABA as a negative regulator of insulin secretion.\",\n      \"method\": \"Transgenic mouse overexpression (RIP7-hGAD65), in vivo glucose tolerance tests, pancreas perfusion experiments\",\n      \"journal\": \"American journal of physiology. Endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean transgenic loss/gain of function with defined physiological phenotype, pancreas perfusion functional assay, single lab\",\n      \"pmids\": [\"10950838\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"GAD65 autoantibodies enhance presentation of the immunodominant GAD65 274-286 epitope to T cells via Fc receptor-mediated uptake; enhancement is inhibited by anti-FcR monoclonal antibodies, demonstrating that antibody-complexed GAD65 is taken up by antigen-presenting cells through FcR.\",\n      \"method\": \"T-cell hybridoma stimulation assay, Fc receptor blocking with monoclonal antibodies, antigen presentation assay\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional blocking experiment with defined molecular mechanism, single lab\",\n      \"pmids\": [\"11016444\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Phosphorylation of GAD65 by protein kinase C epsilon activates GAD65 enzymatic activity; this effect is reversible by protein phosphatases. In contrast, GAD67 is inhibited by PKA-mediated phosphorylation at threonine 91 (T91), confirmed by site-directed mutagenesis (T91A abolishes phosphorylation and inhibition; T91D/E mimics phosphorylation effect).\",\n      \"method\": \"In vitro kinase assay with purified recombinant proteins, [32P]ATP incorporation, anti-phosphoserine/threonine immunoblotting, MALDI-TOF phosphosite identification, site-directed mutagenesis\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — in vitro reconstitution with purified recombinant proteins, radioisotope incorporation, MS phosphosite mapping, and mutagenesis validation in one study\",\n      \"pmids\": [\"15147202\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In GAD65 knockout mice, synaptic vesicles lacking GAD65 show upregulated VGAT expression and more efficiently transport cytosolic GABA into vesicles; both full-length and N-terminally truncated GAD65 bind to GABAergic synaptic vesicles, indicating the N-terminus is not required for vesicle anchoring; GAD65 plays a major role in GABA synthesis for synaptic transmission under normal physiological conditions.\",\n      \"method\": \"GAD65 knockout mouse studies, synaptic vesicle reconstitution assay with [3H]glutamate, Western blotting for VGAT\",\n      \"journal\": \"Brain research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — genetic knockout combined with in vitro vesicle reconstitution assay and domain truncation analysis\",\n      \"pmids\": [\"17482148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"GAD65 undergoes a palmitoylation cycle: prior to palmitoylation, GAD65 anchors to both ER and Golgi membranes; palmitoylation at Cys30 and Cys45 clears GAD65 from ER-Golgi and targets it to the trans-Golgi network and then to post-Golgi vesicular pathway toward presynaptic clusters. FRAP analysis identifies a rapid non-palmitoylated pool exchanging between cytosol and ER/Golgi, and a slow palmitoylation-competent pool replenishing Golgi via a non-vesicular depalmitoylation-repalmitoylation cycle.\",\n      \"method\": \"FRAP (fluorescence recovery after photobleaching), live-cell imaging of GAD65-GFP, palmitoylation-deficient mutant analysis\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — FRAP with functional mutants, direct live-cell trafficking analysis, multiple orthogonal approaches in one study\",\n      \"pmids\": [\"18230651\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Crystal structure analysis of GAD65 reveals that B-cell autoepitopes cluster in two regions (ctc1 and ctc2) at the COOH-terminal domain; the C-terminal domain of GAD65 is structurally more flexible than the equivalent region in GAD67, and T-cell epitopes co-localize with B-cell epitope clusters on solvent-exposed surfaces; this structural flexibility likely explains GAD65's greater autoantigenicity compared to GAD67.\",\n      \"method\": \"Crystal structure analysis, mutagenesis-based epitope mapping with 11 human monoclonal antibodies, cross-inhibition radioimmunoprecipitation with recombinant Fab\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — structural analysis combined with comprehensive mutagenesis and functional antibody binding assays\",\n      \"pmids\": [\"18184926\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"The GAD2 (gad2) promoter contains three functional estrogen response elements (EREs): an ERE at -711 is essential for transactivation in both MCF-7 and neural cells; an ERE at -546 enhances transcription specifically in neural cells; an ERE at -1958 is inactive in neural cells but represses transcription in MCF-7 cells. Estradiol activates gad2 transcription via either ERalpha or ERbeta through a CREB-independent mechanism; ChIP confirms ERalpha binding to a DNA fragment containing the -546 and -711 EREs in mouse GABAergic N42 cells.\",\n      \"method\": \"Dual luciferase reporter assays, site-directed mutagenesis of EREs, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — functional promoter mutagenesis combined with ChIP validation in neural cells, multiple orthogonal methods\",\n      \"pmids\": [\"19587286\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BDNF/TrkB signaling controls GAD65 transcription in a cell-autonomous manner in cortical interneurons via a Ras-ERK-CREB-dependent pathway; conditional ablation of TrkB in cortical interneurons causes decreased synaptically enriched GAD65 protein and mRNA levels.\",\n      \"method\": \"Conditional TrkB knockout in cortical interneurons, pharmacological pathway dissection (Ras-ERK-CREB), Western blotting, qRT-PCR\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — cell-type-specific conditional knockout with pathway pharmacological dissection and molecular readouts\",\n      \"pmids\": [\"20739478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Persistent inflammatory and neuropathic pain epigenetically suppresses Gad2 (GAD65) transcription in rat brainstem nucleus raphe magnus through HDAC-mediated histone hypoacetylation, reducing GAD65 protein and impairing GABA synaptic inhibition; Gad2 knockout mice show sensitized pain behavior and impaired GABA synaptic function; HDAC inhibitors restore GAD65 activity and GABA synaptic function only in wild-type, not Gad2 knockout mice.\",\n      \"method\": \"Gad2 knockout mice, HDAC inhibitor treatment, chromatin immunoprecipitation for histone acetylation, electrophysiological recording of GABA synaptic function, behavioral pain assays\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with pharmacological rescue, electrophysiology, and epigenetic ChIP, multiple orthogonal methods\",\n      \"pmids\": [\"21983856\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Mutant huntingtin (mhtt) impairs GAD65 palmitoylation and disrupts its subcellular localization: GAD65 shifts from Golgi membrane association to cytosolic diffusion in cells expressing mhtt; overexpression of HIP14 (the palmitoyl transferase responsible for GAD65 palmitoylation in vivo) rescues both GAD65 palmitoylation and vesicle-associated GAD65 trafficking, establishing HIP14 as the writer of GAD65 palmitoylation.\",\n      \"method\": \"Neuronal cell lines expressing normal or mutant huntingtin, acyl-biotin exchange palmitoylation assay, subcellular fractionation, HIP14 overexpression rescue\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — palmitoylation assay with rescue experiment, single lab, cell line model\",\n      \"pmids\": [\"22103299\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GAD65 undergoes cofactor (PLP)-dependent conformational changes: molecular dynamics simulations reveal coupling between the C-terminal domain, catalytic loop, and PLP-binding domain that drives structural rearrangement, dimer opening, and autoinactivation of GAD65 into an apo form; small-angle X-ray scattering and fluorescence spectroscopy confirm that apoGAD65 exists as a conformational ensemble; antibody-binding kinetics show mutually induced conformational changes, implicating GAD65 structural flexibility in its autoantigenicity.\",\n      \"method\": \"Molecular dynamics simulations, small-angle X-ray scattering (SAXS), fluorescence spectroscopy, limited proteolysis, antibody-binding kinetics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Strong — multiple orthogonal biophysical methods (SAXS, fluorescence, MD, proteolysis) converging on same mechanism\",\n      \"pmids\": [\"24927554\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Prenatal immune activation (poly I:C maternal injection) increases 5-methylcytosine (5mC) levels at the GAD2 promoter region in offspring prefrontal cortex, with elevated MeCP2 binding at the GAD2 promoter, resulting in reduced GAD65 mRNA expression.\",\n      \"method\": \"Bisulfite sequencing/methylation analysis, chromatin immunoprecipitation (MeCP2), qRT-PCR in mouse model\",\n      \"journal\": \"Epigenetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP and methylation analysis with functional mRNA readout, single lab\",\n      \"pmids\": [\"26575259\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Pancreatic islet beta cells release GAD65 (along with IA-2 and proinsulin) in exosomes; anchoring of GAD65 to exosome-mimetic liposomes strongly boosts antigen presentation and T-cell activation in the context of HLA-DR4; cytokine-induced ER stress enhances exosome secretion and promotes exosomal release of immunostimulatory chaperones (calreticulin, Gp96, ORP150).\",\n      \"method\": \"Exosome isolation from rat and human islets, electron microscopy, Western blotting, exosome-mimetic liposome reconstitution, T-cell activation assays\",\n      \"journal\": \"Diabetes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — exosome isolation with reconstitution experiment and functional T-cell readout, single lab\",\n      \"pmids\": [\"27872147\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Orexin cell activation rapidly recruits GAD65-expressing lateral hypothalamic (GAD65LH) neurons; internally initiated GAD65LH cell bursts precede and accompany spontaneous running bouts; selective chemogenetic silencing of GAD65LH neurons depresses voluntary locomotion; GAD65LH cell overactivation leads to hyperlocomotion, establishing this orexin-activated GAD65LH submodule as a governor of physical activity.\",\n      \"method\": \"Optogenetic circuit analysis, chemogenetic (DREADD) silencing, deep-brain calcium recordings in behaving GAD65-GFP mice\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — optogenetics and chemogenetics combined with in vivo recordings, multiple orthogonal methods establishing circuit function\",\n      \"pmids\": [\"28396414\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"HDAC2 knockdown in rat spinal cord via lentiviral shRNA alleviates mechanical and thermal hyperalgesia after chronic constriction injury and increases GAD65 and KCC2 expression in the spinal cord, identifying GAD65 as a downstream target of HDAC2 in pain modulation.\",\n      \"method\": \"Lentiviral HDAC2 shRNA knockdown, Western blotting for GAD65 and KCC2, behavioral pain assays\",\n      \"journal\": \"Frontiers in neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — lentiviral knockdown with defined molecular and behavioral readouts, single lab\",\n      \"pmids\": [\"31024248\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GAD65 is rapidly released from cultured human beta-cells proportional to cell death within 4-24 hours of acute insult, and is detectable in plasma within 24 hours after intraportal islet transplantation in proportion to the number of implanted beta-cells, establishing GAD65 as a real-time marker of beta-cell destruction.\",\n      \"method\": \"Time-resolved fluorescence immunoassay for GAD65, in vitro beta-cell toxin treatment, clinical intraportal transplantation study\",\n      \"journal\": \"The Journal of clinical endocrinology and metabolism\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — functional in vitro assay combined with clinical validation, single group\",\n      \"pmids\": [\"25816051\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"GAD65-knockout rats (generated by TALEN) have undetectable brain GAD65 protein, significantly lower brain GABA content, exhibit spontaneous seizures and paroxysmal EEG discharge at postnatal weeks 3-4, and suffer >80% premature lethality by postnatal days 17-23, demonstrating that GAD65-derived GABA is essential for suppression of epilepsy and survival, with a more severe phenotype in rats than mice reflecting the higher GAD65/GAD67 ratio in rat (and human) brain.\",\n      \"method\": \"TALEN-based GAD2 knockout in rats, Western blotting, immunohistochemistry, GABA quantification, EEG recording, behavioral observation\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic knockout with EEG, biochemical, and histological validation across multiple orthogonal methods\",\n      \"pmids\": [\"33236473\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GAD65/GAD67 double-knockout mice exhibit 100% incidence of cleft palate and omphalocele (compared to 65.8%/58.9% in GAD67-KO alone), with intermediate severity between GAD67-KO and VGAT-KO mice, demonstrating that GAD65-mediated GABAergic transmission contributes to both palate and abdominal wall formation during development.\",\n      \"method\": \"GAD65/GAD67 double knockout mice, anatomical analysis of palate elevation and omphalocele, comparison across genetic knockout lines\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic epistasis via comparison of single and double KO phenotypes, anatomical quantification, single lab\",\n      \"pmids\": [\"25545713\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Adenoviral delivery of GAD65 gene into trigeminal ganglion satellite glial cells leads to GAD65 expression and GABA synthesis predominantly in SGCs; the resulting analgesic effect in the orofacial formalin test is blocked by the selective GABAA receptor antagonist bicuculline but not by GABAB antagonist CGP46381, demonstrating that GAD65-derived GABA acts on neuronal GABAA receptors to reduce pain.\",\n      \"method\": \"Adenoviral gene delivery (AdGAD65), immunohistochemistry, pharmacological receptor blockade, behavioral orofacial formalin pain test\",\n      \"journal\": \"Molecular pain\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — pharmacological dissection of receptor specificity with gene delivery model, single lab\",\n      \"pmids\": [\"19656360\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"The GAD2 promoter SNP -243 A>G increases GAD2 promoter activity approximately 6-fold in the murine insulinoma cell line betaTC3 and induces a 6-fold higher affinity for nuclear extracts, providing a functional mechanism by which this variant could alter GAD65 expression.\",\n      \"method\": \"Reporter gene (luciferase) assay in betaTC3 cells, nuclear extract binding/electrophoretic mobility shift assay\",\n      \"journal\": \"PLoS biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — direct functional promoter assay with nuclear binding, single lab, replicated (though association with obesity not confirmed in later studies)\",\n      \"pmids\": [\"14691540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"LHA GAD65 neurons are intrinsically depolarized and fire action potentials spontaneously (unlike cortical GABAergic interneurons); they fall into four electrophysiological subtypes (fast spiking, late spiking, low threshold spiking, regular spiking); approximately 40% are directly inhibited by physiological increases in extracellular glucose; they do not express MCH or orexin/hypocretin peptides.\",\n      \"method\": \"Whole-cell patch-clamp in acute brain slices of GAD65-GFP transgenic mice, 3D biocytin morphological reconstruction, glucose perfusion experiments, immunohistochemistry\",\n      \"journal\": \"The Journal of physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — electrophysiology combined with morphological and immunochemical characterization, multiple orthogonal methods\",\n      \"pmids\": [\"23184514\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GAD2 encodes GAD65, a PLP-dependent enzyme that synthesizes GABA preferentially at presynaptic terminals; it is anchored to Golgi membranes via a hydrophobic modification and cycles dynamically to post-Golgi vesicular compartments through a HIP14-mediated palmitoylation/depalmitoylation cycle at Cys30/Cys45; its enzymatic activity is activated by PKC-epsilon-mediated phosphorylation and regulated by PLP binding status (existing mainly as an inactive apo form that undergoes cofactor-dependent conformational changes involving C-terminal domain flexibility and dimer opening); GAD65 is the principal isoform supplying GABA for synaptic vesicle loading and activity-dependent inhibitory transmission, as demonstrated by knockout phenotypes (seizures, reduced synaptic GABA, developmental defects), and its transcription is regulated by BDNF/TrkB-Ras-ERK-CREB signaling, estrogen receptor binding to promoter EREs, and HDAC-mediated epigenetic modification.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"GAD2 encodes GAD65, a pyridoxal-5'-phosphate (PLP)-dependent decarboxylase that synthesizes GABA and serves as the principal isoform supplying GABA for synaptic vesicle loading and inhibitory neurotransmission [#8, #21]. The enzyme exists largely as an inactive apo form that undergoes cofactor-dependent conformational changes—coupling between the C-terminal domain, catalytic loop, and PLP-binding domain drives dimer opening and autoinactivation, and the structurally flexible C-terminal region underlies GAD65's marked autoantigenicity relative to GAD67 [#10, #15]. Enzymatic activity is acutely upregulated by PKC-epsilon-mediated phosphorylation, an effect reversible by protein phosphatases, in contrast to PKA-mediated inhibition of GAD67 [#7]. GAD65 is targeted to membranes through a palmitoylation cycle at Cys30/Cys45 written by the palmitoyl transferase HIP14, which clears it from ER/Golgi to the trans-Golgi network and onward via a post-Golgi vesicular pathway toward presynaptic clusters; disruption of this cycle by mutant huntingtin shifts GAD65 to cytosolic diffusion [#9, #14]. Loss of GAD65 lowers brain GABA and causes spontaneous seizures, premature lethality, and developmental defects including cleft palate and omphalocele, and epigenetic suppression of Gad2 underlies inflammatory and neuropathic pain states [#21, #22, #13]. GAD2 transcription is controlled by BDNF/TrkB-Ras-ERK-CREB signaling, estrogen receptor binding to promoter EREs, and HDAC- and MeCP2-mediated epigenetic regulation [#12, #11, #13, #16]. Beyond the nervous system, GAD65 is the predominant islet isoform, acts as a negative regulator of glucose-stimulated insulin secretion, and is a major autoantigen whose release in exosomes and via beta-cell death drives FcR-mediated antigen presentation and T-cell activation [#2, #5, #17, #6].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Established that GAD65 is not neuron-restricted, raising the possibility of non-neurotransmission GABA functions in peripheral tissues.\",\n      \"evidence\": \"Isoform-specific Western, immunohistochemistry, and Northern blotting across peripheral tissues\",\n      \"pmids\": [\"1729406\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No functional role for peripheral GABA defined\", \"Did not address regulation of isoform-specific expression\"]\n    },\n    {\n      \"year\": 1993,\n      \"claim\": \"Showed that GAD65 activity is more PLP-responsive than GAD67 and that the enzyme associates with vesicle-like structures, hinting at distinct cofactor regulation and membrane targeting.\",\n      \"evidence\": \"Retroviral GAD65 expression in Rat-1 fibroblasts with enzymatic assays, immunostaining, and GABA measurement; islet expression analysis by Western/IP/IHC\",\n      \"pmids\": [\"8336154\", \"8243826\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of membrane association not defined\", \"PLP dependence not yet linked to a structural mechanism\"]\n    },\n    {\n      \"year\": 1994,\n      \"claim\": \"Defined GAD2 gene structure and its conservation with GAD1, framing the two GAD genes as products of a common ancestor under independent regulation.\",\n      \"evidence\": \"Genomic cloning, structural characterization, and primer extension\",\n      \"pmids\": [\"8088791\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Regulatory elements not functionally tested\", \"Cis-elements driving cell-type specificity not mapped\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Mapped the GAD65 basal promoter and a distal silencer, establishing the transcriptional control architecture distinct from GAD67.\",\n      \"evidence\": \"Primer extension and deletion reporter assays in brain and P19 cells\",\n      \"pmids\": [\"9445084\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Trans-acting factors at the silencer not identified\", \"Did not link promoter elements to physiological signaling\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Demonstrated a non-neuronal physiological role: GAD65-derived GABA negatively regulates glucose-stimulated insulin secretion in beta-cells.\",\n      \"evidence\": \"RIP7-hGAD65 transgenic mouse overexpression, glucose tolerance tests, pancreas perfusion\",\n      \"pmids\": [\"10950838\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Molecular target at/near K-ATP channel not identified\", \"Loss-of-function not tested in islets\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Identified an FcR-dependent route by which autoantibody-complexed GAD65 enhances antigen presentation, linking the enzyme to autoimmune T-cell activation.\",\n      \"evidence\": \"T-cell hybridoma stimulation with anti-FcR blocking antibodies\",\n      \"pmids\": [\"11016444\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"In vivo relevance to diabetes onset not established\", \"APC type and FcR subtype not fully resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolved isoform-divergent post-translational control: PKC-epsilon phosphorylation activates GAD65 whereas PKA phosphorylation at T91 inhibits GAD67.\",\n      \"evidence\": \"In vitro kinase assays with purified proteins, [32P] incorporation, MALDI-TOF phosphosite mapping, site-directed mutagenesis\",\n      \"pmids\": [\"15147202\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GAD65 phosphosite not pinpointed as precisely as GAD67 T91\", \"Physiological stimulus driving PKC-epsilon phosphorylation not identified\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Genetically established GAD65 as the major source of GABA for synaptic transmission and showed its vesicle anchoring does not require the N-terminus.\",\n      \"evidence\": \"GAD65 knockout mice, synaptic vesicle reconstitution with [3H]glutamate, VGAT Western blotting, truncation analysis\",\n      \"pmids\": [\"17482148\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Vesicle anchoring determinant not mapped\", \"Compensatory VGAT upregulation mechanism unresolved\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Defined the palmitoylation cycle that traffics GAD65 from ER/Golgi to post-Golgi presynaptic vesicular compartments, and identified the C-terminal structural flexibility behind its autoantigenicity.\",\n      \"evidence\": \"FRAP and live-cell imaging with palmitoylation-deficient mutants; crystal structure with antibody epitope mapping\",\n      \"pmids\": [\"18230651\", \"18184926\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Palmitoyl transferase not yet identified in 2008\", \"Depalmitoylation enzyme unknown\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Defined estrogen-responsive transcriptional control of GAD2 via multiple promoter EREs and demonstrated GABAA-receptor-mediated analgesia from glial GAD65 expression.\",\n      \"evidence\": \"Luciferase reporter assays with ERE mutagenesis and ChIP in neural cells; adenoviral GAD65 delivery to satellite glia with pharmacological receptor blockade\",\n      \"pmids\": [\"19587286\", \"19656360\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological estrogen regulation of endogenous GAD2 not shown\", \"Mechanism of glial GABA release not defined\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identified BDNF/TrkB-Ras-ERK-CREB signaling as a cell-autonomous driver of GAD65 transcription in cortical interneurons.\",\n      \"evidence\": \"Conditional TrkB knockout, pharmacological pathway dissection, Western/qRT-PCR\",\n      \"pmids\": [\"20739478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct CREB binding to GAD2 promoter not mapped here\", \"Activity-dependence of the pathway not quantified\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Linked HDAC-mediated epigenetic suppression of Gad2 to impaired GABAergic inhibition in chronic pain, with HDAC inhibitor rescue requiring intact GAD65.\",\n      \"evidence\": \"Gad2 knockout mice, HDAC inhibitor treatment, histone-acetylation ChIP, electrophysiology, pain behavior\",\n      \"pmids\": [\"21983856\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific HDAC isoform not identified in this study\", \"Recruitment of HDAC to Gad2 not mechanistically defined\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified HIP14 as the palmitoyl transferase writing GAD65 palmitoylation and showed mutant huntingtin disrupts GAD65 membrane targeting.\",\n      \"evidence\": \"Acyl-biotin exchange palmitoylation assay, subcellular fractionation, HIP14 overexpression rescue in neuronal cell lines\",\n      \"pmids\": [\"22103299\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single cell-line model, no in vivo confirmation\", \"Functional consequence for GABA transmission not measured\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Defined the PLP-dependent conformational mechanism of GAD65 autoinactivation and its developmental requirement in palate and abdominal wall formation.\",\n      \"evidence\": \"MD simulations, SAXS, fluorescence spectroscopy, limited proteolysis, antibody kinetics; GAD65/GAD67 double-knockout anatomical analysis\",\n      \"pmids\": [\"24927554\", \"25545713\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Conformational ensemble not captured at atomic resolution in apo state\", \"Developmental GABA target tissues not defined\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed beta-cells release GAD65 in exosomes that potently boost antigen presentation, and that orexin-activated lateral hypothalamic GAD65 neurons govern voluntary physical activity.\",\n      \"evidence\": \"Exosome isolation, liposome reconstitution, T-cell assays; optogenetics, chemogenetic silencing, and in vivo calcium recordings in GAD65-GFP mice\",\n      \"pmids\": [\"27872147\", \"28396414\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trigger linking ER stress to exosomal GAD65 in vivo unresolved\", \"Downstream targets of GAD65LH neurons not fully mapped\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrated that GAD65-knockout rats recapitulate a severe seizure/lethality phenotype proportional to high GAD65 ratio and that circulating GAD65 marks real-time beta-cell destruction.\",\n      \"evidence\": \"TALEN GAD2 knockout rats with EEG, biochemistry, histology; time-resolved immunoassay in cultured beta-cells and transplant patients\",\n      \"pmids\": [\"33236473\", \"25816051\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of species-dependent severity not molecularly defined\", \"Clearance kinetics of plasma GAD65 not characterized\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How acute post-translational regulation (PKC phosphorylation, PLP cofactor cycling, HIP14 palmitoylation) is coordinated in vivo to match GABA supply to activity-dependent inhibitory demand remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No integrated in vivo model linking trafficking, cofactor state, and phosphorylation\", \"Depalmitoylating enzyme for GAD65 unidentified\", \"GAD65 phosphosite for PKC-epsilon not precisely mapped\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0016830\", \"supporting_discovery_ids\": [1, 7]},\n      {\"term_id\": \"GO:0016829\", \"supporting_discovery_ids\": [1, 7, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005794\", \"supporting_discovery_ids\": [9, 14]},\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [9]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [8, 9]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [8, 21]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [22, 12]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [11, 12, 13]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6, 17]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"HIP14\", \"VGAT\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"faith_supported":7,"faith_total":7,"faith_pct":100.0}}